54 results
8-K
XENE
Xenon Pharmaceuticals Inc
2 Jun 22
Departure of Directors or Certain Officers
4:03pm
, please refer to the disclosure found under “Executive Compensation—Employee Benefit and Stock Plans—Amended and Restated 2014 Equity Incentive Plan
8-K
ji83mx08s
10 Mar 22
Results of Operations and Financial Condition
4:09pm
424B5
6cd56q3ck4x 02evub3
1 Mar 22
Prospectus supplement for primary offering
5:12pm
424B5
qn659poinzqhjfe84
6 Oct 21
Prospectus supplement for primary offering
5:05pm
424B5
hat8g iv14yj
4 Oct 21
Prospectus supplement for primary offering
5:27pm
8-K
oj91wtzu
12 Mar 21
Departure of Directors or Certain Officers
5:03pm
8-K
huxi7d c0
13 Mar 20
Departure of Directors or Certain Officers
4:05pm
424B5
x3of6ocvvg7gi4sc8x
23 Jan 20
Prospectus supplement for primary offering
4:44pm
424B5
j3ukl7qvew 8cd
22 Jan 20
Prospectus supplement for primary offering
4:11pm